Spark Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Spark Investment Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,100	Closed	-$118K	–	65
2020 Q3	$118K	Sell	10,100 -8,300	-45%	-$101K	0.16%	41
2020 Q2	$271K	Sell	18,400 -24,900	-58%	-$368K	0.99%	22
2020 Q1	$584K	Hold	43,300	–	–	0.31%	109
2019 Q4	$1.05M	Sell	43,300 -16,400	-27%	-$340K	0.12%	237
2019 Q3	$1.15M	Sell	59,700 -61,200	-51%	-$1.4M	0.15%	174
2019 Q2	$3.57M	Sell	120,900 -36,300	-23%	-$1.4M	0.25%	123
2019 Q1	$7.47M	Hold	157,200	–	–	0.35%	84
2018 Q4	$5.67M	Buy	+157,200	New	+$7.37M	0.39%	82
2016 Q2	–	Sell	-161,900	Closed	-$1.97M	–	872
2016 Q1	$1.97M	Buy	+161,900	New	+$2.56M	0.2%	173

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Spark Investment Management's AERI Position: Q4 2020 in Review

Spark Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2020, closing a stake of 10,100 shares — an estimated $118K sold.

Spark Investment Management first reported a position in AERI in Q1 2016 and held it in 9 quarters. The position peaked at $7.47M in Q1 2019. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.

Spark Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Spark Investment Management sold 10,100 Aerie Pharmaceuticals shares in Q4 2020, an estimated $118K.
Spark Investment Management first reported a position in Aerie Pharmaceuticals in Q1 2016 and held it in 9 quarters.
Spark Investment Management's Aerie Pharmaceuticals position peaked at $7.47M in Q1 2019.
150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.

Based on Spark Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.